Breaking News

Antheia Fulfills First Commercial Delivery of Thebaine

Continues to progress the development of additional products in its pipeline, including oripavine and scopolamine.

Antheia, a pharmaceutical ingredient manufacturer, has delivered its first commercial order of thebaine to a leading pharmaceutical customer. Antheia’s first commercial delivery of thebaine is a full-scale order that will be used in the manufacturing of critical medicines. According to the company, this demonstrates its ability to successfully manufacture pharmaceutical ingredients at commercial scale and secure all necessary regulatory approvals for its biosynthetic products.    “Comple...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters